
Experian Wins 2025 HR Tech Award for Tax Withholding Solution
COSTA MESA, Calif.--(BUSINESS WIRE)--Experian ® has been recognized as a 2025 HR Tech Award Winner by Lighthouse Research & Advisory for its Tax Withholding Solution. Experian's product took top honors and was celebrated as a Core HR/Workforce and Best Comprehensive Solution for its ability to help employers, and their employees, overcome many of the complexities associated with tax withholding.
The recognition marks the second consecutive year Experian has received this prestigious award, highlighting its commitment to innovation and excellence in HR technology. Last year's Verification Fulfillment award recognized Experian's solution to help employers fulfill inbound verification requests seeking employees' employment and income information.
'Our solution is designed to address challenges employers face in tax withholding so they can streamline processes and better serve their employees,' said Anne Obee, vice president of Experian Employer Services. 'This award from Lighthouse Research & Advisory exemplifies our commitment to provide employers with best-in-class solutions that alleviate the administrative burden of tax withholding and compliance so employers can meet the critical responsibility of timely and accurate paychecks to their employees.'
Accurate tax withholding is a vital function for employers, yet they often face several challenges in effectively managing the process, including:
Complexity and compliance: Navigating over 7,000 tax jurisdictions in the U.S. requires extensive knowledge and constant updates to ensure compliance.
Timeliness: Capturing initial and ongoing tax withholding needs accurately and sharing this data securely with appropriate technology platforms is crucial to avoid missing payroll deadlines.
Employee Experience: Providing a smooth, self-service method to collect withholding information, available in multiple languages and accessible 24/7, is essential.
Flexibility: Accommodating employees' evolving life situations, such as changes in life status or location, is necessary for a seamless process.
Experian's award-winning Tax Withholding solution is designed to address these challenges by simplifying the complex process while supporting accurate and timely tax withholding. Experian's subject matter experts have decades of expertise in workforce compliance, and its solution is easy to use, secure and accessible at any time in multiple languages.
'Taxes. It's a topic that makes many people cringe, because the topic is complicated and difficult to understand,' said Ben Eubanks, Chief Research Officer at Lighthouse Research & Advisory. 'Good thing there are organizations like Experian making it easy for employers to withhold taxes in an accurate and timely manner. Their solution supports 7,000 distinct tax jurisdictions, helping employers and the workforce to stay on top of this critical component of payroll and life.'
Lighthouse Research & Advisory presented Experian with the award at the annual UNLEASH America Conference in Las Vegas. During the event, Brian Elfrink, director of product management at Experian, and Gordon Middleton, compliance intelligence manager, participated in two speaking sessions that focused on the intricacies of tax withholding as well as the challenges of workforce compliance and how Experian's solutions help businesses stay compliant with various regulations.
To learn more about Experian's Employer Services business, visit: https://www.experian.com/employer-services/.
About Experian
Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realize their financial goals and help them to save time and money.
We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.
We invest in talented people and new advanced technologies to unlock the power of data and innovate. As a FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 22,500 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
38 minutes ago
- Yahoo
Wedgewood Pharmacy Adds GS-441524 to Its FIP Treatment Portfolio
SWEDESBORO, N.J., June 05, 2025--(BUSINESS WIRE)--Wedgewood Pharmacy today announced the availability of a GS-441524 formula, a compounded oral antiviral formulation now part of its feline infectious peritonitis (FIP) treatment capabilities. With this addition, veterinarians can now prescribe both GS-441524 and Molnupiravir for their patients, two of the most requested compounded antivirals for FIP, through a single trusted source backed by pharmacist support and FDA-registered ingredient sourcing. GS-441524 can be compounded as a 50mg/ml flavored oral oil suspension in multiple sizes, to improve compliance and ease of administration. The addition complements Wedgewood's Molnupiravir formulations, giving veterinarians access to two antivirals with distinct mechanisms of action. "FIP is one of the toughest diagnoses we face, not just clinically, but emotionally too," said Dr. Rae Hutchins, Chief Veterinary Officer at Wedgewood. "For a long time, vets had to deal with inconsistent access and quality when it came to GS-441524. Now, by offering both GS-441524 and Molnupiravir from one trusted, pharmacist-supported source, we're making it easier for veterinarians to focus on what matters most, giving their patients the best possible chance." "Having access to both GS-441524 and Molnupiravir compounded formulations through Wedgewood not only widens access to affordable FIP treatment across the US, but it also gives veterinarians the ability to easily choose and adapt treatment to best suit the needs of their patients and clients," said Nicole Jacque, co-founder of FIP Global Cats. "Having pharmacists who understand the urgency and complexity of these cases partnering with veterinarians is key to ensuring the best treatment outcomes for cats with FIP." Until recently, many veterinarians relied on fragmented or unregulated sources for GS-441524, making it difficult to ensure consistency and continuity of care. The introduction of this option through Wedgewood reflects a direct response to those challenges, providing prescribers with a trusted, quality-assured formulation from a pharmacy they can count on. The launch of GS-441524 builds on Wedgewood's long-standing role in supporting veterinarians with customized treatment solutions for complex cases. As part of its commitment to responsible compounding, the pharmacy emphasizes that its GS-441524 formulation is not approved by the FDA, has not been studied in clinical trials, and Wedgewood makes no claims of efficacy or safety. Independent third-party studies related to GS-441524 are available for veterinary reference through Wedgewood's FIP Resource Center. To learn more about GS-441524 and access educational resources, visit About WedgewoodWedgewood is the nation's largest and most trusted provider of compounded veterinary medications. Its next-generation home delivery platform, Blue Rabbit, streamlines patient care and marks a significant evolution in online pharmacy services. Together, Blue Rabbit and Wedgewood serve more than 70,000 veterinary professionals and more than one million animals annually. For more information visit About FIP Global Cats FIP Global CATS® (Community, Advocacy, Treatment, Support) is a leading organization in the fight against feline infectious peritonitis (FIP). Uniting veterinarians, researchers, and pet owners, it provides crucial support to those facing an FIP diagnosis. The organization is committed to empowering pet parents, advocating for safe, effective and affordable legal treatments, and advancing FIP research. For more information, please visit View source version on Contacts Jennifer Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Wire
40 minutes ago
- Business Wire
Wedgewood Pharmacy Adds GS-441524 to Its FIP Treatment Portfolio
SWEDESBORO, N.J.--(BUSINESS WIRE)--Wedgewood Pharmacy today announced the availability of a GS-441524 formula, a compounded oral antiviral formulation now part of its feline infectious peritonitis (FIP) treatment capabilities. With this addition, veterinarians can now prescribe both GS-441524 and Molnupiravir for their patients, two of the most requested compounded antivirals for FIP, through a single trusted source backed by pharmacist support and FDA-registered ingredient sourcing. "Having access to both GS-441524 and Molnupiravir compounded formulations through Wedgewood not only widens access to affordable FIP treatment across the US, but it also gives veterinarians the ability to easily choose and adapt treatment." Share GS-441524 can be compounded as a 50mg/ml flavored oral oil suspension in multiple sizes, to improve compliance and ease of administration. The addition complements Wedgewood's Molnupiravir formulations, giving veterinarians access to two antivirals with distinct mechanisms of action. 'FIP is one of the toughest diagnoses we face, not just clinically, but emotionally too,' said Dr. Rae Hutchins, Chief Veterinary Officer at Wedgewood. 'For a long time, vets had to deal with inconsistent access and quality when it came to GS-441524. Now, by offering both GS-441524 and Molnupiravir from one trusted, pharmacist-supported source, we're making it easier for veterinarians to focus on what matters most, giving their patients the best possible chance.' "Having access to both GS-441524 and Molnupiravir compounded formulations through Wedgewood not only widens access to affordable FIP treatment across the US, but it also gives veterinarians the ability to easily choose and adapt treatment to best suit the needs of their patients and clients,' said Nicole Jacque, co-founder of FIP Global Cats. 'Having pharmacists who understand the urgency and complexity of these cases partnering with veterinarians is key to ensuring the best treatment outcomes for cats with FIP.' Until recently, many veterinarians relied on fragmented or unregulated sources for GS-441524, making it difficult to ensure consistency and continuity of care. The introduction of this option through Wedgewood reflects a direct response to those challenges, providing prescribers with a trusted, quality-assured formulation from a pharmacy they can count on. The launch of GS-441524 builds on Wedgewood's long-standing role in supporting veterinarians with customized treatment solutions for complex cases. As part of its commitment to responsible compounding, the pharmacy emphasizes that its GS-441524 formulation is not approved by the FDA, has not been studied in clinical trials, and Wedgewood makes no claims of efficacy or safety. Independent third-party studies related to GS-441524 are available for veterinary reference through Wedgewood's FIP Resource Center. To learn more about GS-441524 and access educational resources, visit About Wedgewood Wedgewood is the nation's largest and most trusted provider of compounded veterinary medications. Its next-generation home delivery platform, Blue Rabbit, streamlines patient care and marks a significant evolution in online pharmacy services. Together, Blue Rabbit and Wedgewood serve more than 70,000 veterinary professionals and more than one million animals annually. For more information visit About FIP Global Cats FIP Global CATS® (Community, Advocacy, Treatment, Support) is a leading organization in the fight against feline infectious peritonitis (FIP). Uniting veterinarians, researchers, and pet owners, it provides crucial support to those facing an FIP diagnosis. The organization is committed to empowering pet parents, advocating for safe, effective and affordable legal treatments, and advancing FIP research. For more information, please visit
Yahoo
an hour ago
- Yahoo
2Modern Welcomes Nicole Andrew as Chief Marketing Officer
MILL VALLEY, Calif., June 05, 2025--(BUSINESS WIRE)--2Modern, a leading retailer for modern design since 2003, proudly announces the appointment of Nicole Andrew as Chief Marketing Officer (CMO). Reporting directly to CEO Greg Finney, Andrew joins the executive leadership team with 17 years in luxury retail & e-commerce marketing and merchandising, including a deep expertise in the design industry. As CMO, Andrew will lead all aspects of marketing, including brand strategy, performance marketing, creative, partnerships, and customer acquisition and retention. Her focus will be on accelerating growth and enhancing the customer experience, marking a pivotal moment as 2Modern enters a new chapter of expansion in the premium design space. Andrew most recently served as Chief Marketing Officer at Perigold, where she played a key role in shaping the brand's identity and driving significant growth over her eight year tenure. Her leadership, strategic vision, and digital expertise helped position Perigold as a standout in luxury e-commerce. "We're thrilled to welcome Nicole to the 2Modern leadership team," said CEO Greg Finney. "Her track record of building strong brands and her deep passion for design make her a perfect fit for our next stage of growth." "I'm incredibly excited to join 2Modern at such a dynamic time," said Andrew. "In just a few weeks, we've already begun reimagining the customer journey, strengthening storytelling across channels, and identifying new opportunities for growth. I've long admired 2Modern's commitment to authentic, elevated design and look forward to building on that legacy." About 2Modern 2Modern is a leading retailer of modern furniture, lighting, and home accessories, dedicated to bringing timeless design into contemporary living spaces. Established in 2003, 2Modern is focused on partnering with iconic and emerging global design brands to inspire customers and elevate interiors through thoughtful, forward-thinking design. For more information, please visit and follow @2modern on Instagram, Facebook, and Pinterest. View source version on Contacts press@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data